IS7467A - Lansóprasólfjölgervingar og aðferðir við að framleiða þá - Google Patents

Lansóprasólfjölgervingar og aðferðir við að framleiða þá

Info

Publication number
IS7467A
IS7467A IS7467A IS7467A IS7467A IS 7467 A IS7467 A IS 7467A IS 7467 A IS7467 A IS 7467A IS 7467 A IS7467 A IS 7467A IS 7467 A IS7467 A IS 7467A
Authority
IS
Iceland
Prior art keywords
lansoprazole
producing
methods
multiple synthesis
synthesis
Prior art date
Application number
IS7467A
Other languages
English (en)
Inventor
Finkelstein Nina
Wizel Shlomit
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS7467A publication Critical patent/IS7467A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7467A 2002-03-27 2004-09-23 Lansóprasólfjölgervingar og aðferðir við að framleiða þá IS7467A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36782002P 2002-03-27 2002-03-27
PCT/US2003/009261 WO2003082857A2 (en) 2002-03-27 2003-03-27 Lansoprazole polymorphs and processes for preparation thereof

Publications (1)

Publication Number Publication Date
IS7467A true IS7467A (is) 2004-09-23

Family

ID=28675405

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7467A IS7467A (is) 2002-03-27 2004-09-23 Lansóprasólfjölgervingar og aðferðir við að framleiða þá

Country Status (15)

Country Link
US (1) US20040010151A1 (is)
EP (1) EP1476442A2 (is)
JP (1) JP2005533755A (is)
KR (1) KR20040093187A (is)
CN (1) CN1681802A (is)
AU (1) AU2003224779A1 (is)
CA (1) CA2480352A1 (is)
HR (1) HRP20040979A2 (is)
IL (1) IL164153A0 (is)
IS (1) IS7467A (is)
MX (1) MXPA04009384A (is)
NO (1) NO20044606L (is)
PL (1) PL373539A1 (is)
WO (1) WO2003082857A2 (is)
ZA (1) ZA200407799B (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
ES2534713T3 (es) * 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
CN102775388B (zh) 2004-09-13 2016-01-20 武田药品工业株式会社 氧化化合物的制备方法和制备装置
EP1681056A1 (en) 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
EP2007768A2 (en) * 2006-04-20 2008-12-31 Teva Pharmaceutical Industries Ltd Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
EP2089379A4 (en) * 2006-12-07 2010-04-21 Hetero Drugs Ltd NEW CRYSTALLINE SHAPE OF LANSOPRAZOLE
WO2008083341A1 (en) 2006-12-29 2008-07-10 Il Yang Pharmaceutical Company, Ltd. Crystalline forms of solvated ilaprazole
IT1391758B1 (it) * 2008-11-11 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo amorfo
IT1392813B1 (it) * 2009-02-06 2012-03-23 Dipharma Francis Srl Forme cristalline di dexlansoprazolo
KR20100101405A (ko) * 2009-03-09 2010-09-17 한미홀딩스 주식회사 비결정형의 (+)-란소프라졸 제조방법 및 이에 사용되는 (+)-란소프라졸 알코올레이트
WO2011004387A2 (en) * 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
CN102108076B (zh) * 2009-12-23 2014-07-23 江苏豪森医药集团有限公司 制备无定形右兰索拉唑的方法
WO2011121548A1 (en) * 2010-03-31 2011-10-06 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
WO2012095859A1 (en) * 2011-01-12 2012-07-19 Hetero Research Foundation Polymorphs of dexlansoprazole salts
CR20200220A (es) 2013-11-15 2020-11-18 Akebia Therapeutics Inc FORMAS SÓLIDAS DE ÁCIDO {[5-(3-CLOROFENIL)-3-HIDROXIPIRIDIN-2-CARBONIL]AMINO}ACÉTICO, COMPOSICIONES, Y USOS DE LAS MISMAS (Divisional 2016-0222)
CN103664889B (zh) * 2013-12-19 2014-11-19 悦康药业集团有限公司 一种兰索拉唑化合物
CN104844576B (zh) * 2015-04-28 2017-03-08 山东罗欣药业集团股份有限公司 一种兰索拉唑或右旋兰索拉唑晶型化合物及其制备方法
CN104829594A (zh) * 2015-05-15 2015-08-12 苗怡文 一种治疗胃溃疡的药物兰索拉唑化合物
CN104958276A (zh) * 2015-07-30 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物兰索拉唑组合物胶囊
CN104997738A (zh) * 2015-08-10 2015-10-28 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃病的药物兰索拉唑组合物干混悬剂
CN107011328B (zh) * 2017-05-05 2019-10-15 广州大光制药有限公司 一种兰索拉唑化合物的晶型及其结晶制备方法
CN108794450B (zh) * 2018-07-24 2022-08-19 浙江恒康药业股份有限公司 制备无定型右旋兰索拉唑的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
EP1191025B1 (en) * 1999-06-30 2005-06-22 Takeda Pharmaceutical Company Limited Crystals of lansoprazole
HU229356B1 (en) * 2000-12-01 2013-11-28 Takeda Pharmaceutical Process for the crystallization of (r)- or (s)-lansoprazole
CN1876647A (zh) * 2001-02-02 2006-12-13 特瓦制药工业有限公司 苯并咪唑化合物产品

Also Published As

Publication number Publication date
AU2003224779A1 (en) 2003-10-13
EP1476442A2 (en) 2004-11-17
IL164153A0 (en) 2005-12-18
JP2005533755A (ja) 2005-11-10
NO20044606L (no) 2004-10-26
PL373539A1 (en) 2005-09-05
HRP20040979A2 (en) 2005-06-30
WO2003082857A3 (en) 2003-12-18
WO2003082857A2 (en) 2003-10-09
ZA200407799B (en) 2006-07-26
KR20040093187A (ko) 2004-11-04
MXPA04009384A (es) 2005-01-25
CN1681802A (zh) 2005-10-12
US20040010151A1 (en) 2004-01-15
CA2480352A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
IS7467A (is) Lansóprasólfjölgervingar og aðferðir við að framleiða þá
NO20031776L (no) Null-boringskomplettering og produksjonssystem
CY2015015I1 (el) Παραγωγη τιακουμυκινης
IS7725A (is) Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
IS2775B (is) Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
IS8061A (is) Kerfi og aðferð við að framleiða sérsniðna fóðringu fyrir gervilimi
NO20055633D0 (no) Oralt snusprodukt og fremgangsmate for a fremstille snusproduktet
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
ATE298778T1 (de) Fischer-tropsch-syntheseverfahren
NO20020344L (no) Anordninger og fremgangsmater for nedihulls separasjon
IS7645A (is) Stillar glúkósteraviðtaka og aðferð
IS7369A (is) Aðferð og tæki til örflögunýmyndunar
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20043902L (no) Kontrollert syntese av ziprasidon og sammensetninger derav
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
IS7351A (is) Kristölluð karvedílól á föstu formi og aðferðir til að framleiða þau
DK1641832T3 (da) Fremgangsmåde til fremstilling af fiberholdig pektin og produkter og anvendelser heraf
NO20034283D0 (no) Fremgangsmåte og anordning for fremstilling av syntesegass
NO20034282L (no) Fremgangsmate og anordning for fremstilling av syntesegass
NO20043032L (no) Fremgangsmate og anordning for fremstilling av borstehar
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20033797D0 (no) Metode og formel for anti-tumor og anti-metastatisk virkning
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
DK1589938T3 (da) Mundplejesammensætninger og fremgangsmåder hertil
DK2305689T3 (da) Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser